Cellulitis
Drug research and approvals for cellulitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 18, 2026, 12 studies of cellulitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 2 drug trials for it since 2013.
- Recruiting worldwide: 12
- Trials authorized in Canada: 2
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting now
Newest start dates first, of 12 recruiting on ClinicalTrials.gov ↗- A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis,…NCT07896226 · Phase 4 · Tejs Ehlers Klug · starts Nov 1, 2026
- Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic DermatitisNCT07333378 · Not applicable · Pontificia Universidad Catolica de Chile · starts Sep 29, 2026
- Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'NCT07532941 · Phase 4 · Murdoch Childrens Research Institute · starts Aug 18, 2026
- Perspectives on Antibiotics and Tracking Symptoms in ChildrenNCT07093749 · Not applicable · Murdoch Childrens Research Institute · starts Sep 16, 2025
- Transoral Ultrasound Versus no Transoral Ultrasound in Diagnostic Workup of Peritonsillar AbscessNCT07577232 · Not applicable · Copenhagen University Hospital, Rigshospitalet · starts Jun 9, 2025
- Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA InfectionsNCT06982105 · Phase 4 · Indiana University · starts May 20, 2025
- Intravenous Versus Oral Treatment of the Main Acute InfectionsNCT06715306 · Not applicable · University of Southern Denmark · starts Jan 15, 2025
- Complicated Infections in OtorhinolaryngologyNCT06023550 · Not reported · University Medical Centre Ljubljana · starts Sep 1, 2024
- Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled TrialNCT05899140 · Phase 4 · Frieder Schaumburg · starts Mar 15, 2024
- Cellulitis Optimal Antibiotic TreatmentNCT05584007 · Phase 3 · University of Southampton · starts Aug 29, 2023
Drug pipeline
2 approved, 7 in phase 3, 3 in phase 2; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Tazobactam, Piperacillin
- Vancomycin
- Phase 3 Peptidoglycan inhibitor
- Cefazolin
- Phase 3 Bacterial penicillin-binding protein inhibitor
- Moxifloxacin
- Phase 3 Topoisomerase IV inhibitor
- Linezolid
- Phase 3 Bacterial 70S ribosome inhibitor
- Oritavancin
- Phase 3 Peptidoglycan inhibitor
- Dalbavancin
- Phase 3 Peptidoglycan inhibitor
- Floxacillin
- Phase 3 Bacterial penicillin-binding protein inhibitor
- Probenecid
- Phase 2 Solute carrier family 22 member 6 inhibitor
- Cephalexin anhydrous
- Phase 2 Bacterial penicillin-binding protein inhibitor
- Levofloxacin anhydrous
- Phase 2 DNA gyrase inhibitor
How its trials ended
151 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 46 whose ending is known, 61% met their primary endpoint, 13% missed it and 26% stopped early.
- Completed, result not reported7046%
- Met its primary endpoint2819%
- Ongoing2013%
- Status unknown1510%
- Missed its primary endpoint64%
- Stopped: other or unclear53%
- Stopped: enrollment or feasibility43%
- Stopped: funding21%
- Stopped: lack of efficacy11%
Trials authorized in Canada
Newest first; search them all in Canada trials| Jul 14, 2026 | Naproxen versus placebo as adjunct treatment of cellulitis: a randomized controlled trialNaproxen | Ottawa Hospital Research Institute | Pending |
| Jan 15, 2026 | Dexamethasone vs. placebo in children and youth hospitalized for orbital cellulitis: the vision pilot randomized clinical trialDexamethasone | The Hospital for Sick Children | Pending |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA